FPH Declares NZD 0.2235 Dividend, Equivalent to AUD 0.1944 for H1 FY25
Fisher & Paykel Healthcare has updated its dividend announcement to include the Australian Dollar equivalent, providing clearer insight for investors ahead of the mid-December payment.
- Dividend declared for six months ending 30 September 2025
- Total dividend of NZD 0.2235 per share, equivalent to AUD 0.1944
- Dividend fully unfranked with a supplementary component
- Payment scheduled for 16 December 2025
- No approvals required for dividend payment
Dividend Update Brings Currency Clarity
Fisher & Paykel Healthcare Corporation Limited (ASX, FPH) has provided an important update to its recent dividend announcement, specifying the Australian Dollar (AUD) equivalent of its ordinary dividend for the first half of the 2025 financial year. This move enhances transparency for Australian investors who hold the New Zealand Dollar (NZD) denominated shares.
The company declared an ordinary dividend of NZD 0.22352941 per fully paid ordinary share, which translates to approximately AUD 0.19435435 using the exchange rate disclosed on 11 December 2025. This dividend relates to the six-month period ending 30 September 2025 and will be paid on 16 December 2025.
Unfranked Dividend with Supplementary Component
Notably, the dividend is fully unfranked, meaning it does not carry Australian franking credits. This is typical for companies domiciled outside Australia, such as Fisher & Paykel Healthcare, which is based in New Zealand. Alongside the ordinary dividend, a supplementary dividend of NZD 0.03352941 per share has also been declared, also unfranked, reflecting the company’s tax position and cross-border dividend distribution practices.
The record date for entitlement to this dividend is 4 December 2025, with the ex-dividend date set a day earlier on 3 December 2025. Importantly, the company has confirmed that no external approvals; such as security holder or regulatory consents; are required ahead of the dividend payment.
Implications for Investors and Market Observers
For investors, the clarification of the AUD equivalent dividend amount is a welcome update that aids in precise yield calculations and portfolio income forecasting. Given the currency conversion element, fluctuations in the NZD/AUD exchange rate could impact the final AUD value received by Australian shareholders. This update also underscores Fisher & Paykel Healthcare’s commitment to clear communication with its cross-border investor base.
While the announcement does not signal any change in dividend policy or future guidance, it provides a timely reminder of the nuances involved in investing in foreign-listed securities. Analysts and investors will likely incorporate this data point into their valuation models and income projections as the payment date approaches.
Bottom Line?
With the AUD dividend figure now clear, investors can better assess their returns as Fisher & Paykel Healthcare’s December payout approaches.
Questions in the middle?
- How might future currency fluctuations affect Fisher & Paykel Healthcare’s dividend attractiveness to Australian investors?
- Will the company maintain its current dividend level and unfranked status in upcoming periods?
- Could changes in cross-border tax regulations impact the supplementary dividend component?